Switch theme
Sign up to access all valuation multiples
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
2014
2.2K+
LTM Revenue $681M
LTM EBITDA $99.9M
$625M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Avanos Medical has a last 12-month revenue (LTM) of $681M and a last 12-month EBITDA of $99.9M.
In the most recent fiscal year, Avanos Medical achieved revenue of $688M and an EBITDA of -$346M.
Avanos Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Avanos Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $681M | XXX | $688M | XXX | XXX | XXX |
| Gross Profit | $681M | XXX | $381M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $99.9M | XXX | -$346M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | -50% | XXX | XXX | XXX |
| EBIT | n/a | XXX | $40.5M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | 6% | XXX | XXX | XXX |
| Net Profit | -$386M | XXX | -$392M | XXX | XXX | XXX |
| Net Margin | -57% | XXX | -57% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $27.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Avanos Medical's stock price is $13.
Avanos Medical has current market cap of $581M, and EV of $625M.
See Avanos Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $625M | $581M | XXX | XXX | XXX | XXX | $1.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Avanos Medical has market cap of $581M and EV of $625M.
Avanos Medical's trades at 0.9x EV/Revenue multiple, and -1.8x EV/EBITDA.
Equity research analysts estimate Avanos Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Avanos Medical has a P/E ratio of -1.5x.
See valuation multiples for Avanos Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $581M | XXX | $581M | XXX | XXX | XXX |
| EV (current) | $625M | XXX | $625M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 6.3x | XXX | -1.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 15.4x | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.5x | XXX | -1.5x | XXX | XXX | XXX |
| EV/FCF | 7.5x | XXX | 7.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAvanos Medical's last 12 month revenue growth is 0%
Avanos Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Avanos Medical's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Avanos Medical's rule of X is 15% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Avanos Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | -50% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 8% | XXX | -50% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Avanos Medical acquired XXX companies to date.
Last acquisition by Avanos Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Avanos Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Avanos Medical founded? | Avanos Medical was founded in 2014. |
| Where is Avanos Medical headquartered? | Avanos Medical is headquartered in United States of America. |
| How many employees does Avanos Medical have? | As of today, Avanos Medical has 2.2K+ employees. |
| Who is the CEO of Avanos Medical? | Avanos Medical's CEO is Mr. David C. Pacitti. |
| Is Avanos Medical publicy listed? | Yes, Avanos Medical is a public company listed on NYS. |
| What is the stock symbol of Avanos Medical? | Avanos Medical trades under AVNS ticker. |
| When did Avanos Medical go public? | Avanos Medical went public in 2014. |
| Who are competitors of Avanos Medical? | Similar companies to Avanos Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Avanos Medical? | Avanos Medical's current market cap is $581M |
| What is the current revenue of Avanos Medical? | Avanos Medical's last 12 months revenue is $681M. |
| What is the current revenue growth of Avanos Medical? | Avanos Medical revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Avanos Medical? | Current revenue multiple of Avanos Medical is 0.9x. |
| Is Avanos Medical profitable? | Yes, Avanos Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Avanos Medical? | Avanos Medical's last 12 months EBITDA is $99.9M. |
| What is Avanos Medical's EBITDA margin? | Avanos Medical's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Avanos Medical? | Current EBITDA multiple of Avanos Medical is 6.3x. |
| What is the current FCF of Avanos Medical? | Avanos Medical's last 12 months FCF is $82.9M. |
| What is Avanos Medical's FCF margin? | Avanos Medical's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Avanos Medical? | Current FCF multiple of Avanos Medical is 7.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
